Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

2,489

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

2,489 results for “Sars-CoV-2”

Learn how ShareScore rates datasets ↗
zenodo28/100

Supplementary material 1 from: Padilla-Sanchez V (2021) SARS-CoV-2 Structural Analysis of Receptor Binding Domain New Variants from United Kingdom and South Africa. Research Ideas and Outcomes 7: e62936. https://doi.org/10.3897/rio.7.e62936

RBD-ACE2 complexes

opencc-zeroJan 2021View details →
zenodo28/100

Supplementary material 2 from: Padilla-Sanchez V (2021) SARS-CoV-2 Structural Analysis of Receptor Binding Domain New Variants from United Kingdom and South Africa. Research Ideas and Outcomes 7: e62936. https://doi.org/10.3897/rio.7.e62936

RBD-ACE2 interface detail

opencc-zeroJan 2021View details →
zenodo28/100

Figure 1 from: Padilla-Sanchez V (2021) SARS-CoV-2 Structural Analysis of Receptor Binding Domain New Variants from United Kingdom and South Africa. Research Ideas and Outcomes 7: e62936. https://doi.org/10.3897/rio.7.e62936

Figure 1 SARS-CoV-2 viral infection at atomic resolution. Counting eight viruses, each of which has spikes (big protrusions) and E membrane proteins (small protrusions) rainbow colored and a core in sienna color, this picture shows how the viruses approach the cell membrane (green). The ACE2 receptors are colored magenta. The field of view is 1 micrometer.

opencc-by-4.0Jan 2021View details →
zenodo28/100

Figure 3 from: Padilla-Sanchez V (2021) SARS-CoV-2 Structural Analysis of Receptor Binding Domain New Variants from United Kingdom and South Africa. Research Ideas and Outcomes 7: e62936. https://doi.org/10.3897/rio.7.e62936

Figure 3 Detail of interface between ACE2 and SARS-CoV-2 RBD. Amino acids are labeled as well as distances. For more details please see the movies in supplementary files. Wild type is beige, UK variant is light blue and SA variant is pink (Suppl. material 2, Suppl. material 3).

opencc-by-4.0Jan 2021View details →
zenodo28/100

Figure 2 from: Padilla-Sanchez V (2021) SARS-CoV-2 Structural Analysis of Receptor Binding Domain New Variants from United Kingdom and South Africa. Research Ideas and Outcomes 7: e62936. https://doi.org/10.3897/rio.7.e62936

Figure 2 Spike glycoprotein bound to ACE2 receptor. PDB 7DF4 (Xu et al. 2020) where ACE2 is cyan and the spike has been colored red, yellow and blue for each subunit of the trimer. This structure has been recently determined at atomic resolution. In spheres, we can see the mutations in the spike glycoprotein from the United Kingdom variant but the only mutation in the receptor binding domain (magenta) is N501Y which is labeled.

opencc-by-4.0Jan 2021View details →
zenodo28/100

Changes in 25-(OH) vitamin D levels during the SARS-CoV-2 outbreak: lockdown-related effects and first-to-second wave difference.

<p>25-(OH)D concentrations dataset</p> <p>&nbsp;</p>

opencc-by-4.0Dec 2020View details →
zenodo28/100

Datasets associated with the manuscript "Discovering SARS-CoV-2 neoepitopes and the associated TCR-pMHC recognition mechanisms by combining single-cell sequencing, deep learning, and molecular dynamics simulation techniques"

<p>meta_data_TCR-pMHC_from_STCRDab.tsv, TCR-pMHC structures used for contacts analysis.</p><p>tcr_gliph_input_sars2.tsv, input files (TCR sequences and related information) used for clustering TCRs targeting SARS-CoV-2 epitopes and epitope-unknown TCRs.</p><p>tcr_gliph_input_non-sars2.tsv, input files used for clustering TCRs targeting non-SARS-CoV-2 epitopes and epitope-unknown TCRs.</p><p>tcr_gliph_output*, output files from the GLIPH software, including the recognized TCR clusters by GLIPH (convergence-group.txt), the linkage information of TCR clusters (clone-network.txt), and the recognized motif in TCR clusters (kmer.txt).</p><p>md_trajs.tar, structures and MD simulation trajectories of TCR-614-pMHC and TCR-204-pMHC complexes.</p>

opencc-by-4.0Oct 2023View details →
zenodo28/100

Detection of SARS-CoV-2 E and N mRNA at 12 h after co-transfection with SARS-CoV-2 E and N plasmids.

Open the record for dataset details and reuse information.

opencc-by-4.0Dec 2023View details →
zenodo28/100

Fits and plot data for the paper: "Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants"

Open the record for dataset details and reuse information.

opencc-by-4.0Nov 2023View details →
zenodo28/100

Genomic spectrograms of subsamplings from complete sequences of SARS-CoV-2

Open the record for dataset details and reuse information.

opencc-by-4.0Mar 2024View details →
zenodo28/100

Exploring Conformational Landscapes and Binding Mechanisms of Convergent Evolition for the SARS-CoV-2 Spike Omicron Variant Complexes with the ACE2 Receptor Using AlphaFold2-Based Structural Ensembles and Molecular Dynamics Simulations

Open the record for dataset details and reuse information.

opencc-by-4.0Mar 2024View details →
zenodo28/100

Reliability of CNEURO hyssops for sample collection in the SARS-CoV-2 diagnosis

<p>Abstract</p> <p>Background:&nbsp;The detection of SARS-CoV-2 genetic material from nasopharyngeal swab samples by RT-PCR is the most specific and sensitive way to test suspected cases. However, factors such as the sampling process, type of hyssop used, and the anatomical area from which the sample is collected can distort the result and cause false negatives.</p> <p>Objective:&nbsp;to evaluate the reliability of CNUERO hyssops for sample collection in the SARS-CoV-2 diagnosis versus IMPROSWAB hyssops.</p> <p>Methods:&nbsp;To study the reliability of hyssops developed in Cuba for swabbing in the COVID-19 diagnosis, by comparing them to other hyssops successfully used for this task, 2 swabbing samples were obtained from each patient (136). One of these two samples was taken using the hyssops made in Cuba, while the other was taken employing another hyssop imported from Germany.</p> <p>The positive detections between both hyssops were compared using the Fisher exact test. The result of the detection of each hyssop was evaluated and compared using the ROC curve. &nbsp;</p> <p>Results:&nbsp;The use of CNEURO hyssops allowed detecting 45 out of 59 positive cases, while IMPROSAWAB hyssops detected 52 out of 59. Non-significant differences were detected between positive cases detected for each hyssop. The sensibility of sample detection using CNEURO hyssops was of 76.3 % and of 88.1 % when using IMPROSWAB hyssops. Hence, no significant differences are detected in the detection of cases using these two hyssops.</p> <p>Conclusion:&nbsp;CNEURO hyssops are safe and reliable to be used for nasopharyngeal samples taking of COVID-19 patients.</p>

opencc-by-4.0Nov 2021View details →
zenodo28/100

Raw diffraction data for structure of SARS-CoV-2 main protease with ABT-957 (PDB: 7QT8)

<p>Raw diffraction data for SARS-CoV-2 main protease in complex with ABT-957 collected as part of an room-temperature crystallographic ligand screening experiments on beamline i24 at Diamond Light Source.</p>

opencc-by-4.0Jan 2022View details →
zenodo28/100

Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors - minimum dataset

<p>This is the minimum dataset to reproduce the statistical analysis performed in the manuscript entitled &quot;Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors&quot; by P&eacute;rez-Al&oacute;s, L. et al. (2022).</p>

opencc-by-nc-sa-4.0Feb 2022View details →
dryad28/100

Adverse drug reactions to the three doses of the SARS-COV-2 mRNA-1273 vaccine in a cohort of cancer patients of a tertiary hospital

<p><strong>Introduction:</strong> SARS-CoV-2 vaccines efficacy and safety have been tested in phase 3 studies in which cancer patients were not included or underrepresented. Information is scarce regarding safety in this population. </p> <p><strong>Methods:</strong> The objective of this study is to evaluate the safety profile of the mRNA-1273 vaccine across cancer  patients and its relationship to patients' demographics. This cross sectional study included patients 18-years or older with solid malignancies receiving active treatment in our hospital who had received the three dose schedule of the mRNA9 1273 vaccine and whose side effects after each dose were recorded. Patient electronic medical records were reviewed retrospectively to collect tha available information in 2021. Patients with documented previous infection by SARS-Cov-2 were excluded from the study.</p> <p><strong>Results:</strong> 93 patients met inclusion criteria. Local adverse drug reactions (ADRs) were reported more frequently after the first and second dose than after the third (41.9%, 43% and 31.1% of the patients respectively), while systemic ADRs were reported less frequently after the first and second dose than after the third (16.1%, 34.4% and 52.6% of the patients respectively). We found  a statistically significant association between sex and systemic ADRs after the third dose.  Cochran-Armitage test showed a statistically significant linear trend, p = 0.012, with higher ECOG score associated with a lower proportion of patients suffering from systemic side effects. A logistic regression showed that females had 5.79 times higher odds to exhibit systemic ADRs after the third dose (p=0.01)  compared to males. Increasing age was associated with a decreased likelihood of exhibiting ADRs (p=0.016).</p> <p><strong>Conclusion:</strong> mRNA-1273 vaccine shows a tolerable safety profile. The likelihood of ADRs appears to be associated with gender and age. Its association with ECOG scores is less evident. Further studies are needed to elucidate this data in cancer patients.<span></span></p>

opencc-zeroMar 2022View details →
zenodo28/100

Figure 7 from: Shoman ME, Abd El-Hafeez AA, Khobrani M, Assiri AA, Al Thagfan SS, Othman EM, Ibrahim ARN (2022) Molecular docking and dynamic simulations study for repurposing of multitarget coumarins against SARS-CoV-2 main protease, papain-like protease and RNA-dependent RNA polymerase. Pharmacia 69(1): 211-226. https://doi.org/10.3897/pharmacia.69.e77021

Figure 7 2D poses of (A) Mesuol; (B) Isomesuol; (C) suksdorphin; (D) Calanolide; docked into the active site of SARS-CoV-2 main protease (PDB: 5rh4).

opencc-by-4.0Mar 2022View details →
zenodo28/100

Figure 6 from: Shoman ME, Abd El-Hafeez AA, Khobrani M, Assiri AA, Al Thagfan SS, Othman EM, Ibrahim ARN (2022) Molecular docking and dynamic simulations study for repurposing of multitarget coumarins against SARS-CoV-2 main protease, papain-like protease and RNA-dependent RNA polymerase. Pharmacia 69(1): 211-226. https://doi.org/10.3897/pharmacia.69.e77021

Figure 6 (A) surface map (B) 2D poses showing ligand interactions of Coumermycin docked into the active site of SARS-CoV-2 main protease (PDB: 5rh4).

opencc-by-4.0Mar 2022View details →
zenodo28/100

Figure 12 from: Shoman ME, Abd El-Hafeez AA, Khobrani M, Assiri AA, Al Thagfan SS, Othman EM, Ibrahim ARN (2022) Molecular docking and dynamic simulations study for repurposing of multitarget coumarins against SARS-CoV-2 main protease, papain-like protease and RNA-dependent RNA polymerase. Pharmacia 69(1): 211-226. https://doi.org/10.3897/pharmacia.69.e77021

Figure 12 The time frame of evolution against the radius of gyration (Rg) of Coumermycin complexes with SARS-CoV-2 (A) Mpro (B) PLpro (C) RdRp, during 50 ns MD simulation.

opencc-by-4.0Mar 2022View details →
zenodo28/100

Figure 11 from: Shoman ME, Abd El-Hafeez AA, Khobrani M, Assiri AA, Al Thagfan SS, Othman EM, Ibrahim ARN (2022) Molecular docking and dynamic simulations study for repurposing of multitarget coumarins against SARS-CoV-2 main protease, papain-like protease and RNA-dependent RNA polymerase. Pharmacia 69(1): 211-226. https://doi.org/10.3897/pharmacia.69.e77021

Figure 11 The RMSF plot of Coumermycin complex with SARS-CoV-2 (A) Mpro (B) PLpro (C) RdRp, at 50 ns simulation.

opencc-by-4.0Mar 2022View details →
zenodo28/100

Figure 5 from: Shoman ME, Abd El-Hafeez AA, Khobrani M, Assiri AA, Al Thagfan SS, Othman EM, Ibrahim ARN (2022) Molecular docking and dynamic simulations study for repurposing of multitarget coumarins against SARS-CoV-2 main protease, papain-like protease and RNA-dependent RNA polymerase. Pharmacia 69(1): 211-226. https://doi.org/10.3897/pharmacia.69.e77021

Figure 5 2D poses of (A) Novobiocin; (C) Clorobiocin; (B) hydroxychloroquine; (D) N3; docked into the active site of SARS-CoV-2 main protease.

opencc-by-4.0Mar 2022View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record